Skip to main content
Naftali Kaminski, MD, Pulmonology, New Haven, CT

NaftaliKaminskiMD

Pulmonology New Haven, CT

Interstitial Lung Diseases

Chief of Pulmonary, Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Tenured Professor of Internal Medicine and Pharmacology. Boehringer-Ingelheim Endowed Chair.

Dr. Kaminski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kaminski's full profile

Already have an account?

Summary

  • Dr. Naftali Kaminski is a Physician-Scientists in New Haven, CT and a tenured professor of medicine, and the Chief of Pulmonary, Critical Care and Sleep Medicine at Yale and Yale-New Haven Hospital. He received his medical degree from The Hebrew University of Jerusalem Hadassah Medical School. He completed his Internal Medicine residency in Hadassah Mount-Scopus University Hospital, his Pulmonary Fellowship in Sheba Medical center in Tel-Hashomer, Israel, and a research fellowship at UCSF. Kaminski was the founding Director of the Simmons Center for Interstitial Lung Disease, and has joined Yale as the Chief of Yale-OCCSM in 2013. He specializes in interstitial lung diseases and is renowned for his groundbreaking research, leadership and advocacy. He has been a recipient of multiple awards and recognitions, and is the past president of the Association of Pulmonary, Critical Care and Sleep Division Chiefs.

Education & Training

  • Yale University
    Yale UniversityMA, 2013
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicinePost-Doctoral Fellowship, Lung Biology and Genomics, 1996 - 2000
  • Universityof California San Francisco
    Universityof California San FranciscoPhD, Cellular and Molecular Biology Functional Genomics and Microarray Technology, 2000
  • The Hebrew University of Jerusalem Hadassah Medical School
    The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1989
  • Hebrew University - Hadassah Medical School (Biology Medical Sciences)
    Hebrew University - Hadassah Medical School (Biology Medical Sciences)BS, 1985

Awards, Honors, & Recognition

  • J. Burns Amberson Honorary Lecture Award American Thoracic Society, 2022
  • Blavatnik Innovation Fund Award Yale, 2019
  • Andy Tager Mentorship Award American Thoracic Society, Assembly of Respiratory Cell and Molecular Biology, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reducing Protein Oxidation Reverses Lung Fibrosis  
    David J Seward, Ralph C Budd, Charles G Irvin, Kevin K Brown, Kelly J Butnor, Naftali Kaminski, Nature
  • Nrf2 Amplifies Oxidative Stress via Induction of Klf9  
    Zucker SN, Fink EE, Bagati A, Mannava S, Bianchi-Smiraglia A, Bogner PN, Wawrzyniak J, Foley C, Leonova K, Grimm M, Moparthy K, Ionov Y, Wang J, Liu S, Sexton S, Kande..., Molecular Cell, 1/1/2014
  • Serum Lysyl Oxidase Like-2 Levels and Idiopathic Pulmonary Fibrosis Disease Progression  
    Chien JW, Richards TJ, Gibson KF, Zhang Y, Lindell KO, Shao L, Lyman SK, Adamkewicz JI, Smith V, Kaminski N, O'Riordan T, Eur Respir J, 1/31/2013
  • Join now to see all

Books/Book Chapters

Lectures

  • Treatment target - non coding RNAs in IPF 
    Quebec, Canada - 1/1/2014
  • Genomic Research in Sarcoidosis: the GRADS Trial 
    University of Ohio - 1/1/2014
  • Pulmonary Fibrosis: New Biomarkers and Mechanisms 
    University of Tennessee Chattanooga - 1/1/2014
  • Join now to see all

Press Mentions

  • After Elon Musk Acquisition, Will #ScienceTwitter #MedTwitter Move to Mastodon, Other Platforms?
    After Elon Musk Acquisition, Will #ScienceTwitter #MedTwitter Move to Mastodon, Other Platforms?November 6th, 2022
  • 2022 Respiratory Health Awardees
    2022 Respiratory Health AwardeesMay 9th, 2022
  • Public Advisory Roundtable Amplifies Patient Voices Through Forum, Symposium, Speakers
    Public Advisory Roundtable Amplifies Patient Voices Through Forum, Symposium, SpeakersApril 26th, 2022
  • Join now to see all

Professional Memberships